MiR-1203 is involved in hepatocellular carcinoma metastases and indicates a poor prognosis
- Free access
Abstract:
Non-coding RNAs, especially miRNAs, have been shown to be important regulators in multiple human diseases, including malignant tumors, congenital disease, and autoimmune disease. In this study, we screened the metastasis-associated miRNAs in hepatocellular carcinoma (HCC). Based on the miRNA microarray screening, miR-1203 was confirmed to be the most significant miRNA and was also highly associated with HCC metastases. Bioinformatics prediction indicated direct binding of miR-1203 in SOCS3, which was also confirmed by a dual luciferase reporter assay, resulting in suppression of SOCS3. Increased miR-1203 also promoted invasion of HCC cells through suppressing SOCS3, while no effect on cell proliferation or apoptosis was detected. Circulating expression of miR-1203 and SOCS3 might serve as a predictor of metastases and poor prognosis in HCC patients. In conclusion, miR-1203 might promote HCC metastasis by decreasing SOCS3. MiR-1203 predicts a poor outcome in HCC patients and thus might serve as a potential therapeutic target for the prevention of HCC.
Received date: 04/14/2019
Accepted date: 06/26/2019
Ahead of print publish date: 12/17/2019
Issue: 2/2020
Volume: 67
Pages: 267 — 276
Keywords: miRNA, biomarker, metastasis, hepatocellular carcinoma, SOCS3
DOI: 10.4149/neo_2019_190414N328